Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Methadone maintenance therapy is the cornerstone of treatment for heroin addiction. Hyperhidrosis is a common and often-overlooked side effect of methadone. Different medications, such as antihistamines and anticholinergic drugs, have been reported to be effective against opioid-induced sweating, but there is no standardized therapy. A 51-year-old patient under methadone maintenance therapy reported long-standing hyperhidrosis, which worsened each time the methadone dosage was increased. After substituting methadone with levomethadone, while maintaining equivalent dosages, the patient reported a stark reduction in sweating. Therefore, levomethadone could be a promising alternative for patients in methadone maintenance therapy who suffer from methadone-induced hyperhidrosis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/10550887.2024.2443696 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Machine learning model for predicting hepatitis C seroconversion in methadone maintenance patients in China.
BMJ Public Health
August 2025
Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Introduction: Hepatitis C virus (HCV) infection is a substantial public health concern, particularly among individuals with opioid addiction. The methadone maintenance treatment (MMT) programmes serve as a harm reduction strategy to mitigate HIV disease spread, yet the risk of HCV infection remains high within these settings. Accurate risk prediction for HCV seroconversion is therefore crucial for improving patient outcomes.
View Article and Find Full Text PDFBuprenorphine maintenance treatment and its outcome among opioid dependent pregnant women: A case series from India.
Indian J Psychiatry
August 2025
National Drug Dependence Treatment Centre, AIIMS, New Delhi, India.
Perinatal opioid use is the major public health concern worldwide due to its hazardous effect on the mother and the developing fetus. Opioid agonist maintenance treatment with buprenorphine or methadone has been the recommended treatment for opioid dependence during pregnancy for various reasons. There is scarcity of literature in this regard.
View Article and Find Full Text PDFCardiac Assessment of Individuals with Opioid Use Disorder under Methadone Treatment.
J Res Pharm Pract
August 2025
Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran.
Objective: Methadone treatment is effective for managing opioid use disorder (OUD) but raises concerns about its impact on cardiac function. This study aimed to assess the prevalence of cardiac dysfunction among individuals under methadone treatment.
Methods: This cross-sectional study involved 200 OUD patients admitted to addiction treatment centers of Kerman, Iran, who were at least 1 year under methadone maintenance therapy.
Restrictive State Opioid Treatment Program Regulations Constrain Local Access To Methadone Maintenance Treatment.
Health Aff (Millwood)
September 2025
Paul J. Joudrey, University of Pittsburgh.
State regulations governing opioid treatment programs (OTPs) vary widely in their restrictiveness, but how they affect geographic access to methadone maintenance treatment for opioid use disorder remains poorly understood. In this study of comprehensive data on methadone shipments to OTPs in 2019, we found that ZIP codes just across the border in states with low restrictiveness in OTP regulations had more than twice the OTP density and methadone shipments compared with nearby and otherwise similar ZIP codes in states with high restrictiveness. These findings suggest that restrictive state OTP regulations constrain geographic access to methadone maintenance treatment and that easing such restrictions is a viable strategy to expand access.
View Article and Find Full Text PDFPost-cesarean opioid consumption in patients on maintenance medication for opioid use disorder undergoing cesarean delivery with neuraxial anesthesia: a single-center retrospective propensity-matched cohort study (2016-2020).
Int J Obstet Anesth
July 2025
Department of Anesthesiology, University of Florida - Jacksonville, Jacksonville, FL, USA. Electronic address:
Background: Scheduled multimodal non-opioid analgesics after cesarean delivery are effective in reducing opioid consumption. However, there is limited information regarding the effectiveness of this practice for reducing opioid consumption in patients on opioid agonists (methadone or buprenorphine) for an opioid use disorder. We hypothesized that standardized neuraxial anesthesia with neuraxial morphine and multimodal non-opioid analgesics would result in similar postoperative opioid consumption between patients on opioid agonist therapy and opioid-naïve controls.
View Article and Find Full Text PDF